203 related articles for article (PubMed ID: 31387068)
1. Pharmaceutically active compounds in aqueous environment: A status, toxicity and insights of remediation.
Majumder A; Gupta B; Gupta AK
Environ Res; 2019 Sep; 176():108542. PubMed ID: 31387068
[TBL] [Abstract][Full Text] [Related]
2. Occurrence, fate and ecotoxicological assessment of pharmaceutically active compounds in wastewater and sludge from wastewater treatment plants in Chongqing, the Three Gorges Reservoir Area.
Yan Q; Gao X; Chen YP; Peng XY; Zhang YX; Gan XM; Zi CF; Guo JS
Sci Total Environ; 2014 Feb; 470-471():618-30. PubMed ID: 24176710
[TBL] [Abstract][Full Text] [Related]
3. Pharmaceutically active compounds in aqueous environment: recent developments in their fate, occurrence and elimination for efficient water purification.
Bangia S; Bangia R; Daverey A
Environ Monit Assess; 2023 Oct; 195(11):1344. PubMed ID: 37857877
[TBL] [Abstract][Full Text] [Related]
4. Occurrence and fate of pharmaceutical pollutants in wastewater: Insights on ecotoxicity, health risk, and state-of-the-art removal.
Nguyen MK; Lin C; Bui XT; Rakib MRJ; Nguyen HL; Truong QM; Hoang HG; Tran HT; Malafaia G; Idris AM
Chemosphere; 2024 Apr; 354():141678. PubMed ID: 38485003
[TBL] [Abstract][Full Text] [Related]
5. Analysis and advanced oxidation treatment of a persistent pharmaceutical compound in wastewater and wastewater sludge-carbamazepine.
Mohapatra DP; Brar SK; Tyagi RD; Picard P; Surampalli RY
Sci Total Environ; 2014 Feb; 470-471():58-75. PubMed ID: 24140682
[TBL] [Abstract][Full Text] [Related]
6. An overview of homogeneous and heterogeneous photocatalysis applications for the removal of pharmaceutical compounds from real or synthetic hospital wastewaters under lab or pilot scale.
Antonopoulou M; Kosma C; Albanis T; Konstantinou I
Sci Total Environ; 2021 Apr; 765():144163. PubMed ID: 33418323
[TBL] [Abstract][Full Text] [Related]
7. Photo-transformation of pharmaceutically active compounds in the aqueous environment: a review.
Yan S; Song W
Environ Sci Process Impacts; 2014 Apr; 16(4):697-720. PubMed ID: 24608883
[TBL] [Abstract][Full Text] [Related]
8. Membrane processes for removal of pharmaceutically active compounds (PhACs) from water and wastewaters.
Taheran M; Brar SK; Verma M; Surampalli RY; Zhang TC; Valero JR
Sci Total Environ; 2016 Mar; 547():60-77. PubMed ID: 26789358
[TBL] [Abstract][Full Text] [Related]
9. Predictive models for the degradation of 4 pharmaceutically active compounds in municipal wastewater effluents by the UV/H
Shi Y; Shen G; Geng J; Fu Y; Li S; Wu G; Wang L; Xu K; Ren H
Chemosphere; 2021 Jan; 263():127944. PubMed ID: 32854006
[TBL] [Abstract][Full Text] [Related]
10. Occurrence and fate of pharmaceutically active compounds in the largest municipal wastewater treatment plant in Southwest China: mass balance analysis and consumption back-calculated model.
Yan Q; Gao X; Huang L; Gan XM; Zhang YX; Chen YP; Peng XY; Guo JS
Chemosphere; 2014 Mar; 99():160-70. PubMed ID: 24268750
[TBL] [Abstract][Full Text] [Related]
11. A review of the biotransformations of priority pharmaceuticals in biological wastewater treatment processes.
Nguyen PY; Carvalho G; Reis MAM; Oehmen A
Water Res; 2021 Jan; 188():116446. PubMed ID: 33038717
[TBL] [Abstract][Full Text] [Related]
12. Ecotoxicological risk of pharmaceuticals from wastewater treatment plants in Korea: occurrence and toxicity to Daphnia magna.
Han GH; Hur HG; Kim SD
Environ Toxicol Chem; 2006 Jan; 25(1):265-71. PubMed ID: 16494251
[TBL] [Abstract][Full Text] [Related]
13. Biodegradability, environmental risk assessment and ecological footprint in wastewater technologies for pharmaceutically active compounds removal.
Dos Santos CR; Lebron YAR; Moreira VR; Koch K; Amaral MCS
Bioresour Technol; 2022 Jan; 343():126150. PubMed ID: 34678454
[TBL] [Abstract][Full Text] [Related]
14. Occurence and Prioritization of Pharmaceutical Active Compounds in Domestic/Municipal Wastewater Treatment Plants.
Vergili I; Kaya Y; Gönder ZB; Boergers A; Tuerk J
Bull Environ Contam Toxicol; 2019 Feb; 102(2):252-258. PubMed ID: 30666389
[TBL] [Abstract][Full Text] [Related]
15. Hospital wastewater treatment by fungal bioreactor: removal efficiency for pharmaceuticals and endocrine disruptor compounds.
Cruz-Morató C; Lucas D; Llorca M; Rodriguez-Mozaz S; Gorga M; Petrovic M; Barceló D; Vicent T; Sarrà M; Marco-Urrea E
Sci Total Environ; 2014 Sep; 493():365-76. PubMed ID: 24951894
[TBL] [Abstract][Full Text] [Related]
16. Removal of pharmaceutical compounds in water and wastewater using fungal oxidoreductase enzymes.
Naghdi M; Taheran M; Brar SK; Kermanshahi-Pour A; Verma M; Surampalli RY
Environ Pollut; 2018 Mar; 234():190-213. PubMed ID: 29175684
[TBL] [Abstract][Full Text] [Related]
17. Pharmaceutically active compounds: Their removal during slow sand filtration and their impact on slow sand filtration bacterial removal.
D'Alessio M; Yoneyama B; Kirs M; Kisand V; Ray C
Sci Total Environ; 2015 Aug; 524-525():124-35. PubMed ID: 25889551
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of pharmaceutically active compounds in aqueous solution by UV/CaO
Zheng M; Daniels KD; Park M; Nienhauser AB; Clevenger EC; Li Y; Snyder SA
Water Res; 2019 Nov; 164():114922. PubMed ID: 31382152
[TBL] [Abstract][Full Text] [Related]
19. The impact of wastewater matrix on the degradation of pharmaceutically active compounds by oxidation processes including ultraviolet radiation and sulfate radicals.
Sbardella L; Velo-Gala I; Comas J; Rodríguez-Roda Layret I; Fenu A; Gernjak W
J Hazard Mater; 2019 Dec; 380():120869. PubMed ID: 31307000
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceuticals in water and sediment of small streams under the pressure of urbanization: Concentrations, interactions, and risks.
Kondor AC; Molnár É; Jakab G; Vancsik A; Filep T; Szeberényi J; Szabó L; Maász G; Pirger Z; Weiperth A; Ferincz Á; Staszny Á; Dobosy P; Horváthné Kiss K; Hatvani IG; Szalai Z
Sci Total Environ; 2022 Feb; 808():152160. PubMed ID: 34864023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
